icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

China’s Hemp Market

With global demand for hemp surging, China’s sector is poised for years of dramatic growth. In 2017, Chinese hemp sales totaled $1.1 billion (USD), approaching 1/3 of the $3.1 billion global market, with sales forecasted to grow to $1.5 billion (up 36%) by 2020. In 2017, textiles accounted for about 3/4 of China’s overall sales […]
Read more

China’s Hemp Market

With global demand for hemp surging, China’s sector is poised for years of dramatic growth. In 2017, Chinese hemp sales totaled $1.1 billion (USD), approaching 1/3 of the $3.1 billion global market, with sales forecasted to grow to $1.5 billion (up 36%) by 2020. In 2017, textiles accounted for about 3/4 of China’s overall sales […]
Read more

Investors Waking Up to Hemp as Cannabis Stocks Retrace

By Sean Murphy, Director of Hemp Analytics, New Frontier Data Investors are waking up to the hemp industry. Hemp is proving its opportunity for financial returns, and potential for social and environmental impact. While the first five years of the cannabis stock “green rush” was dominated by retail over-the-counter (OTC) traders, family offices and high […]
Read more

Differing State Hemp Regulations, Fees, Present Knotty Choices for Cultivators

By J.J. McCoy, Senior Managing Editor, New Frontier Data Not that the expanding patchwork of licensing regulations for hemp programs throughout the United States can be confusing and uneven, but had Johnny Appleseed faced all the challenges now confronting prospective American cultivators, he might have just stayed home. Make no mistake: Industrial hemp represents booming business, […]
Read more

Ask Our Experts 10/21/2018

  Q: I know that Thailand is legalizing medical cannabis, but other Southeast Asian countries do not seem to be in a rush to do so. What will it take for other Asian countries to get onboard with cannabis reform?   Most Asian countries are far from full cannabis legalization, however, what used to be considered […]
Read more

Illinois Legalizes Industrial Hemp

By Larry Mishkin, Hoban Law Group, Litigation Practice Group Counsel Last month, Illinois Gov. Bruce Rauner signed into law Senate Bill 2298, the Illinois Industrial Hemp Act, which became effective immediately. The act allows Illinois farmers, in conjunction with a university or other recognized research group, to cultivate industrial hemp for research and commercial purposes. […]
Read more

Ask Our Experts 10/21/2018

I know that Thailand is legalizing medical cannabis, but other Southeast Asian countries do not seem to be in a rush to do so. What will it take for other Asian countries to get onboard with cannabis reform? Most Asian countries are far from full cannabis legalization, however, what used to be considered fringe movements […]
Read more

Mile High Labs Funding Round Underscores Contrasts in Cannabis Wholesaling

By J.J. McCoy, Senior Managing Editor, New Frontier Data Mile High Labs caught attention last week with the company’s announcement of a $35 million raise in what was described as the “largest Series A financing in the cannabis market history.” It was a newsworthy claim for the Colorado cannabis extraction company, and demonstrated its commitment toward […]
Read more

Examining the Oceania Cannabis Market

By Yona Torres Editor New Frontier Data  New Frontier Data’s most recent report release is an analysis of the budding cannabis market in Oceania (Australia, New Zealand, and the islands that comprise Melanesia, Micronesia, and Polynesia.) As the legal cannabis industry expands globally, Oceania serves as another example of significant and economically developed countries, including Australia, [...]
Read more

DEA’s Rescheduling of CBD Is No Industry Cure-All

By J.J. McCoy, Senior Managing Editor, for New Frontier Data Recent news that the U.S. Drug Enforcement Agency (DEA) is rescheduling cannabidiol (CBD) for use in FDA-approved medicine was warmly welcomed by the cannabis industry, but it felt confusingly tepid on delivery. Overall, the announcement is a boon for Big Pharma companies looking to develop and […]
Read more
Top